(Q46893247)

26 December 2017

title

Follow-up after intravitreal triamcinolone acetonide for exudative age-related macular degeneration (English)

1 reference

26 December 2017

author name string

Jonas JB

1

1 reference

26 December 2017

Spandau UH

2

1 reference

26 December 2017

Kamppeter BA

3

1 reference

26 December 2017

Harder B

4

1 reference

26 December 2017

publication date

13 January 2006

1 reference

26 December 2017

published in

Eye

1 reference

26 December 2017

volume

21

1 reference

26 December 2017

issue

3

1 reference

26 December 2017

page(s)

387-394

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.eye.6702222

exact match

0 references

cites work

Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

Exudative macular degeneration and intravitreal triamcinolone. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

ICGA-guided laser photocoagulation of occult choroidal neovascularization in age-related macular degeneration. Indocyanine green angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

Intravitreal triamcinolone in recurrence of choroidal neovascularisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

Intravitreal triamcinolone acetonide for exudative age related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

Factors influencing visual acuity after intravitreal triamcinolone acetonide as treatment of exudative age related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

Intereye difference in exudative age-related macular degeneration with minimally classic or occult subfoveal neovascularization after unilateral intravitreal injection of triamcinolone acetonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

Intravitreal triamcinolone for refractory diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

Regression of neovascular iris vessels by intravitreal injection of crystalline cortisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

Triamcinolone acetonide concentration after filtration of the solvent agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

Effect of triamcinolone acetonide on proliferation of retinal endothelial cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

Photodynamic therapy and intravitreal triamcinolone for a subretinal neovascularization in bilateral idiopathic juxtafoveal telangiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

Indocyanine green-mediated photothrombosis with intravitreal triamcinolone acetonide for subfoveal choroidal neovascularization in age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

Pegaptanib for neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynami

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

Intraocular pressure elevation after intravitreal triamcinolone acetonide injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

Pseudo-endophthalmitis after intravitreal injection of triamcinolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

Noninfectious endophthalmitis associated with intravitreal triamcinolone injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

Verteporfin therapy in combination with triamcinolone: published studies investigating a potential synergistic effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

7 January 2021

Inhibition of Intraocular Proliferations with Intravitreal Corticosteriods

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

7 January 2021

The effects of intravitreal triamcinolone acetonide on experimental pre-retinal neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

7 January 2021

Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

7 January 2021

Nontuberculous mycobacterial endophthalmitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

7 January 2021

Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

7 January 2021

Intravitreal triamcinolone and elevated intraocular pressure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702222

7 January 2021

Identifiers

DOI

10.1038/SJ.EYE.6702222

1 reference

26 December 2017

1 reference

26 December 2017